The US District Court for the District of Massachusetts ordered EOFlow (KOSDAQ:294090) to pay $452 million to Massachusetts-based medical device company Insulet Corporation in damages for misappropriating the latter's trade secrets.
The fine comprises $170 million in compensation and $282 million exemplary for willful misappropriation. The South Korean smart wearable drug delivery solution provider's ability to pay the amount remains unclear, according to a press release by Insulet on Wednesday.
Shares of EOFlow plunged nearly 30% at market close on Thursday.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。